New MDMA variants identified for potentially safer psychotherapeutic use
The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy," to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.
Jun 25, 2024
0
0